Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Keratectasia in Patients Undergoing ReLEx SMILE Procedure Evaluated
  • Refractive Surgery/Vision Correction

Keratectasia in Patients Undergoing ReLEx SMILE Procedure Evaluated

Ophthalmology 360
Article Image

Keratectasia did not appear to develop in patients undergoing the Refractive Lenticule Extraction SMILE procedure who had >40% of their tissue altered, according to an initial retrospective analysis presented at the 2018 World Ophthalmology Congress in Barcelona. Among the findings:

  • PTA values ranged between 29% and 53%.
  • Those with PTA <40% and >40% experienced similar visual acuity and manifest refraction.
  • Both groups showed a mean monocular uncorrected distance visual acuity of <0.05 LogMAR 1-year post-treatment.
  • Radius of curvature, Belin-Ambrósio Enhanced Ectasia Display, Corvis Biomechanical Index, and Tomographic Biomechanical Index values progressed similarly in both groups.

The presenters noted that prior studies show visual recovery from ReLEx SMILE is similar to Femto-LASIK, but that in the latter keratectasia can develop in those who had >40% of their tissue altered. They acknowledged that their findings need to be confirmed in larger studies.

Hagen P.  Impact of Increased PTA values on biomechanical indices and visual outcome up to five years after Refractive Lenticule Extraction (ReLEx) SMILE. Poster presented at: 2018 World Ophthalmology Congress; June 16-19, 2018; Barcelona, Spain. https://www.wocabstracts.org/index.cfm?do=ev.viewEv&ev=4433

Share

Related Content

  • Refractive Surgery/Vision Correction

VISUMAX 800 lenticule extraction linked to high satisfaction and spectacle independence

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

  • Refractive Surgery/Vision Correction

Tips to successfully integrate EVO ICL into office-based surgery

Dr. Ling implanting EVO ICL
  • Refractive Surgery/Vision Correction

EVO ICL plays a strategic role in my refractive business model

  • Cornea and External Disease

Who is the ideal candidate for EVO ICL?

  • Cornea and External Disease

Impact of corneal size on refractive surgery outcomes highlighted in new research

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon